These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37237601)

  • 1. CNN-Based Identification of Parkinson's Disease from Continuous Speech in Noisy Environments.
    Faragó P; Ștefănigă SA; Cordoș CG; Mihăilă LI; Hintea S; Peștean AS; Beyer M; Perju-Dumbravă L; Ileșan RR
    Bioengineering (Basel); 2023 Apr; 10(5):. PubMed ID: 37237601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of speech rate and regularity in Parkinson's disease.
    Skodda S
    J Neurol Sci; 2011 Nov; 310(1-2):231-6. PubMed ID: 21849174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
    Kowalska-Taczanowska R; Friedman A; Koziorowski D
    Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysprosody and stimulus effects in Cantonese speakers with Parkinson's disease.
    Ma JK; Whitehill T; Cheung KS
    Int J Lang Commun Disord; 2010; 45(6):645-55. PubMed ID: 19995207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markerless Analysis of Articulatory Movements in Patients With Parkinson's Disease.
    Bandini A; Orlandi S; Giovannelli F; Felici A; Cincotta M; Clemente D; Vanni P; Zaccara G; Manfredi C
    J Voice; 2016 Nov; 30(6):766.e1-766.e11. PubMed ID: 26620259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prosodic analysis of neutral, stress-modified and rhymed speech in patients with Parkinson's disease.
    Galaz Z; Mekyska J; Mzourek Z; Smekal Z; Rektorova I; Eliasova I; Kostalova M; Mrackova M; Berankova D
    Comput Methods Programs Biomed; 2016 Apr; 127():301-17. PubMed ID: 26826900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and differentiation of ataxic and hypokinetic dysarthria in cerebellar ataxia and parkinsonian disorders via wave splitting and integrating neural networks.
    Song J; Lee JH; Choi J; Suh MK; Chung MJ; Kim YH; Park J; Choo SH; Son JH; Lee DY; Ahn JH; Youn J; Kim KS; Cho JW
    PLoS One; 2022; 17(6):e0268337. PubMed ID: 35658000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid CNN-LSTM model with efficient hyperparameter tuning for prediction of Parkinson's disease.
    Lilhore UK; Dalal S; Faujdar N; Margala M; Chakrabarti P; Chakrabarti T; Simaiya S; Kumar P; Thangaraju P; Velmurugan H
    Sci Rep; 2023 Sep; 13(1):14605. PubMed ID: 37669970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convolutional Neural Network-based Speech Enhancement for Cochlear Implant Recipients.
    Mamun N; Khorram S; Hansen JHL
    Interspeech; 2019 Sep; 2019():4265-4269. PubMed ID: 34307643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on Parkinson's disease recognition algorithm based on sample enhancement].
    Zhang Z; Zhao D; Wang Z; Wei L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Feb; 41(1):17-25. PubMed ID: 38403600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Speech disorders in Parkinson patients].
    Kerschan K; Pankl W; Auff E
    Wien Klin Wochenschr; 1998 Apr; 110(8):279-86. PubMed ID: 9615959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson's disease.
    Tykalová T; Rusz J; Švihlík J; Bancone S; Spezia A; Pellecchia MT
    J Neural Transm (Vienna); 2020 Sep; 127(9):1295-1304. PubMed ID: 32651925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy.
    Rusz J; Tykalova T; Novotny M; Zogala D; Sonka K; Ruzicka E; Dusek P
    Neurology; 2021 Nov; 97(21):e2124-e2135. PubMed ID: 34607922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.